Dare Bioscience (DARE) Other Accumulated Expenses (2013 - 2017)

Dare Bioscience (DARE) has 5 years of Other Accumulated Expenses data on file, last reported at $82810.0 in Q4 2017.

• Quarterly Other Accumulated Expenses fell 85.6% year-over-year to $82810.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $82810.0 (down 85.6% YoY) and the FY2017 annual result came in at $82810.0, down 85.6% from the prior year.
• Other Accumulated Expenses retreated to $82810.0 in Q4 2017, from $120000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $883000.0 in Q4 2015 to a low of $17000.0 in Q3 2015.
• A 5-year average of $366425.6 and a median of $335500.0 in 2014 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2015 — Other Accumulated Expenses slumped 94.99% — and 2016, when it surged 3264.71%.
• Tracing DARE's Other Accumulated Expenses over 5 years: stood at $379000.0 in 2013, then slumped by 91.03% to $34000.0 in 2014, then jumped by 2497.06% to $883000.0 in 2015, then slumped by 34.88% to $575000.0 in 2016, then slumped by 85.6% to $82810.0 in 2017.
• The last three Other Accumulated Expenses figures came in at $82810.0 (Q4 2017), $120000.0 (Q2 2017), and $300000.0 (Q1 2017), per Business Quant data.